Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-065253
Filing Date
2017-12-12
Accepted
2017-12-12 17:52:54
Documents
1
Period of Report
2017-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13446
  Complete submission text file 0001209191-17-065253.txt   15949
Mailing Address 1 SUNSET RIDGE LEXINGTON MA 02173
Business Address
AFEYAN NOUBAR (Reporting) CIK: 0001222012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 171252629

Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Reporting) CIK: 0001627639 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 171252630

Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 55 CAMBRIDGE PARKWAY SUITE 800E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 800E CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V General Partner LLC (Reporting) CIK: 0001724575 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 171252628